Cao Jessica K, Detloff Peter J, Gardner Richard G, Stella Nephi
Department of Pharmacology, University of Washington, Seattle, WA, 98195, United States.
Department of Biochemistry and Molecular Genetics, University of Alabama at Birmingham, Birmingham, AL, 35294, United States.
Behav Brain Res. 2018 Jan 30;337:34-45. doi: 10.1016/j.bbr.2017.09.026. Epub 2017 Sep 18.
Huntington's Disease (HD) is an autosomal dominant neurodegenerative disease characterized by gradual deterioration of motor and cognitive functions and development of psychiatric deficits. Animal models provide powerful means to study the pathological processes, molecular dysfunctions and symptoms associated with HD. We performed a longitudinal behavioral study of the newly developed HdhQ350/+ mouse line, a knock-in model that expresses a repeat of 350 glutamines. We found remarkable sex-dependent differences on symptom onset and severity. While both sexes lose weight and grip strength, only HdhQ350/+ males have impaired motor coordination as measured by the rotarod and alterations in gait as measured by the catwalk assay. While HdhQ350/+ females do not exhibit impairment in motor coordination, we found a reduction in dark phase locomotor activity. Male and female HdhQ350/+ mice do not show anxiety as measured by the elevated plus maze or changes in exploration as measured by the open field test. To investigate these sex-dependent differences, we performed western blot analyses of striatal tissue. We measured equal mutant huntingtin protein expression in both sexes and found evidence of aggregation. We found the expected decrease of DARPP-32 expression only in female HdhQ350/+ mice. Remarkably, we found no evidence of reduction in synaptophysin or CB receptors in HdhQ350/+ tissue of either sex. Our study indicates that male and female HdhQ350/+ mice differentially recapitulate select behavioral impairments commonly measured in other HD mouse models with limited sex-dependent changes in recognized histopathological markers. We conclude that expanded polyglutamine repeats influence HD pathogenesis in a sex-dependent manner.
亨廷顿舞蹈症(HD)是一种常染色体显性神经退行性疾病,其特征为运动和认知功能逐渐衰退以及精神障碍的出现。动物模型为研究与HD相关的病理过程、分子功能障碍和症状提供了有力手段。我们对新开发的HdhQ350/+小鼠品系进行了一项纵向行为研究,该品系是一种表达350个谷氨酰胺重复序列的敲入模型。我们发现症状发作和严重程度存在显著的性别差异。虽然两性体重和握力均下降,但只有HdhQ350/+雄性小鼠的运动协调性受损,这通过转棒试验来衡量,其步态改变通过足迹分析来衡量。虽然HdhQ350/+雌性小鼠未表现出运动协调性受损,但我们发现其暗期运动活动减少。通过高架十字迷宫试验衡量,HdhQ350/+雄性和雌性小鼠均未表现出焦虑,通过旷场试验衡量,其探索行为也未发生改变。为了研究这些性别差异,我们对纹状体组织进行了蛋白质免疫印迹分析。我们测量了两性中突变亨廷顿蛋白的等量表达,并发现了聚集的证据。我们仅在雌性HdhQ350/+小鼠中发现了预期的多巴胺和3',5'-环磷腺苷调节磷酸蛋白-32(DARPP-32)表达下降。值得注意的是,我们在两性的HdhQ350/+组织中均未发现突触素或CB受体减少的证据。我们的研究表明,HdhQ350/+雄性和雌性小鼠以不同方式再现了在其他HD小鼠模型中通常测量到的特定行为损伤,而公认的组织病理学标志物的性别依赖性变化有限。我们得出结论,扩展的聚谷氨酰胺重复序列以性别依赖的方式影响HD发病机制。